Laboratorios Farmaceúticos Rovi SA (LABFF)
65.86
0.00 (0.00%)
USD |
OTCM |
Dec 11, 16:00
Laboratorios Farmaceúticos Rovi EPS Diluted (Quarterly): 1.326 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Grifols SA | 0.2183 |
| Pharma Mar SA | -0.2748 |
| Oryzon Genomics SA | 0.0052 |
| Almirall SA | -- |
| CEL-SCI Corp. | -1.365 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 67.79M |
| Revenue (Quarterly) | 245.95M |
| Total Expenses (Quarterly) | 178.14M |
| Enterprise Value | 3.469B |
| Gross Profit Margin (Quarterly) | 66.68% |
| Profit Margin (Quarterly) | 27.56% |
| Earnings Yield | 4.05% |
| Operating Earnings Yield | 5.02% |
| Normalized Earnings Yield | 4.048 |